Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Anti Dermatomycosis Skin Drugs Markets in China
... grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study ... Read More
-
Global Migraine Drugs Market Growth 2024-2030
... Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Migraine Drugs market. Migraine Drugs ... Read More
-
Angelman Syndrome
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
Global Multiple Sclerosis Drugs Market Growth 2024-2030
... market, the Multiple Sclerosis Drugs is forecast to a readjusted size of US$ 20360 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global ... Read More
-
Multiple Sclerosis Drugs Global Market Report 2024
... Inc.; Novartis International AG; F. Hoffmann-La Roche Ltd.; Bayer HealthCare LLC; Pfizer Inc. Multiple Sclerosis Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
... recombinant proteins market size is projected to reach USD 3.2 billion by 2028 from USD 2.2 billion in 2023, at a CAGR of 7.2% during the forecast period. Factors such as rising demand for biologics ... Read More
-
Epilepsy Therapeutics Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Medical Advances Driving Epilepsy Treatment Market Growth In the ever-evolving ... Read More
-
Vaginitis Therapeutics Market Forecasts to 2030 – Global Analysis By Disease Type (Atrophic Vaginitis, Bacterial vaginosis (BV), Trichomoniasis and Other Disease Types), By Treatment (Prescription Drugs, Natural and Herbal Remedies, Over-the-counter (OTC) Drugs and Probiotics and Vaginal Suppositories), Distribution Channel and By Geography
... and Vaginal Suppositories), Distribution Channel and By Geography According to Stratistics MRC, the Global Vaginitis Therapeutics Market is accounted for $3.52 billion in 2023 and is expected to reach $7.01 billion by 2030 growing at ... Read More
-
H3N2 infection - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
2024 Global Forecast for Epilepsy Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Dyskinesia- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Dyskinesia: Understanding Dyskinesia: Overview ... Read More
-
Sepsis- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Sepsis: Understanding Sepsis: Overview ... Read More
-
Rett Syndrome - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Pre-Eclampsia - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Pre-Eclampsia: Understanding ... Read More
-
Vasculitis - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Vasculitis: Understanding ... Read More
-
Myotonic Dystrophy - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Glaucoma Market Insight, Epidemiology And Market Forecast - 2034
... is expected to increase, driven by the launch of emerging therapies. DelveInsight’s analyst projects that the total diagnosed prevalent cases of Corneal Edema in US were approximately 1,149,967 cases in 2022 and these cases are ... Read More
-
Usher Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... has been estimated to be nearly 16,632,421 (Prevalent cases) in 2022 in the 7MM. Most diagnosed Glaucoma patients were estimated in the US, followed by Japan, Germany, and France in 2022. Open Angle Glaucoma is ... Read More
-
Uveitis Market Insight, Epidemiology And Market Forecast - 2034
... glands. It can be classified into two types, i.e., primary Sjogren’s syndrome and secondary Sjogren’s syndrome. Primary Sjogren’s syndrome (pSS) occurs in the absence of other autoimmune diseases and is characterized by keratoconjunctiva sicca (dry ... Read More
-
Fragile X Syndrome - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
2024 Global Forecast for Epilepsy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Glaucoma - Epidemiology Forecast - 2034
... diagnostic techniques facilitating early detection. Approximately 7 million cases of the total diagnosed prevalent cases of glaucoma was estimated in the 7MM in 2023 and indicated to increase in the study period. DelveInsight's estimates indicate ... Read More
-
Factor IX - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Tuberous Sclerosis- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Tuberous ... Read More
Research Assistance
